Home Cart Sign in  
Chemical Structure| 929901-49-5 Chemical Structure| 929901-49-5

Structure of Guadecitabine
CAS No.: 929901-49-5

Chemical Structure| 929901-49-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Guadecitabine, aslo known as SGI-110, is a dinucleotide antimetabolite of a decitabine linked via phosphodiester bond to a guanosine, with potential antineoplastic activity.

Synonyms: SGI-110

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Guadecitabine

CAS No. :929901-49-5
Formula : C18H24N9O10P
M.W : 557.41
SMILES Code : O=C1C2=C(N([C@H]3C[C@H](O)[C@@H](COP(O)(O[C@@H]4[C@@H](CO)O[C@@H](N5C=NC(N)=NC5=O)C4)=O)O3)C=N2)NC(N)=N1
Synonyms :
SGI-110
MDL No. :MFCD28144509

Safety of Guadecitabine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Guadecitabine

epigenetics
DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00409006 Non-small Cell Lung Cancer Phase 2 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fujian, China, 350014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Qingdao, China, 266003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 201900 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 137-701 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Less <<
NCT00409006 - Completed - -
NCT02878785 Acute Myeloid Leukemia Phase 1 Phase 2 Recruiting December 2022 United States, Maryland ... More >> University of Maryland Greenebaum Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Sunita Philip, MPH, CCRP    410-328-8199    sphilip1@umm.edu    Contact: Gary Saum    410-328-1180    gary.saum@umm.edu    Principal Investigator: Maria Baer, MD Less <<
NCT01966289 Metastatic Colorectal Cancer Phase 1 Active, not recruiting December 2019 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT03075826 Myeloproliferative Neoplasms Phase 2 Recruiting December 2019 United States, New York ... More >> New York Weill Cornell Cancer Center at Cornell University Recruiting New York, New York, United States, 10021 Contact: Tania Curcio, NP    212-746-2571    tjc9003@med.cornell.edu Less <<
NCT02892318 Acute Myeloid Leukemia Phase 1 Suspended(Study enrollment on ... More >>hold to evaluate safety and efficacy data.) Less << January 31, 2019 United States, California ... More >> City of Hope Duarte, California, United States, 91010 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, New York The NewYork-Presbyterian Hospital Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Pennsylvania Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 United States, Wisconsin The University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States, 53705 Less <<
NCT02197676 MDS Phase 2 Completed - France ... More >> CH Angers Angers, France, 49 000 CH Avignon Avignon, France, 84000 Centre Hospitalier de La Cote Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93 000 CHU Clémenceau Caen, France, 14033 CHU Henri Mondor Créteil, France, 94010 CHU de Grenoble Grenoble, France, 38043 Centre Hospitalier du Mans Le Mans, France, 72000 CHRU Limoges Limoges, France, 87046 CH Lyon Sud Lyon, France, 69495 Hôpital Paoli Calmettes Marseille, France, 13273 Centre Hospitalier de Meaux Meaux, France, 77100 Clinique Beausoleil (Montpellier) Montpellier, France, 34000 CHU de nantes Nantes, France, 44093 Centre Catherine de Sienne (Nantes) Nantes, France, 44277 CHU de Nice - Hopital de l'Archet 1 Nice, France, 06 202 CHR Orléans Orléans, France, 45000 Hopital St Louis T4 Paris, France, 75475 Centre Hospitalier Joffre Perpignan, France, 66046 CHU de Haut-Lévèque Pessac, France, 33604 CHU de Poitiers Poitiers, France, 86000 Centre Hospitalier de la région d'Annecy Pringy, France, 74374 Centre Henri Becquerel Rouen, France, 76038 Chu Purpan Toulouse, France, 31059 Hopital Purpan Service d'Hématologie Clinique Toulouse, France CHU Bretonneau Tours, France, 37044 CHU Brabois Vandœuvre-lès-Nancy, France, 54511 Less <<
NCT02293993 Acute Myeloid Leukemia Phase 1 Active, not recruiting December 2019 Japan ... More >> kinki Region Kyoto, Japan Kanto Region, Japan Kyusyu Region, Japan Less <<
NCT02684162 Leukemia Myel... More >>oproliferative Diseases Less << Phase 2 Recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02348489 Leukemia, Myeloid, Acute Phase 3 Completed - -
NCT02096055 Leukemia Phase 2 Active, not recruiting April 2026 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03206047 Recurrent Fallopian Tube Carci... More >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 1 Phase 2 Suspended(Pending outcome of t... More >>he DLT period) Less << March 31, 2020 United States, Arizona ... More >> University of Arizona Cancer Center-North Campus Tucson, Arizona, United States, 85719 The University of Arizona Medical Center-University Campus Tucson, Arizona, United States, 85724 United States, California University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States, 60451 University of Chicago Medicine-Orland Park Orland Park, Illinois, United States, 60462 United States, Kansas University of Kansas Clinical Research Center Fairway, Kansas, United States, 66205 United States, Nebraska Nebraska Medicine-Village Pointe Omaha, Nebraska, United States, 68118 University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT03085849 Extensive-stage Small Cell Lun... More >>g Cancer Less << Phase 1 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT03179943 Urothelial Carcinoma Phase 2 Recruiting July 2022 United States, Pennsylvania ... More >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Elizabeth Plimack, MD    215-214-1515 Less <<
NCT03165721 Paraganglioma ... More >> Gastrointestinal Stromal Tumors Carcinoma, Renal Cell Renal Neoplasms Pheochromocytoma Less << Phase 2 Recruiting December 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01752933 Hepatocellular Carcinoma Phase 2 Completed - -
NCT02998567 Castration-Resistant Prostatic... More >> Cancer Non Small Cell Lung Cancer Less << Phase 1 Recruiting December 2019 United Kingdom ... More >> Rpyal Marsden Hospital Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Summen Chauhdry, BSc    02086421326    summen.chaudry@icr.ac.uk    Principal Investigator: Johann de Bono, FRCP          UCLH Recruiting London, United Kingdom, W1T 7HA Contact: James Wilton       James.Wilton@uclh.nhs.uk    Principal Investigator: Dionysis Papadatos-Pastos, FRCP Less <<
NCT01261312 MDS CMML ... More >> AML Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States, 85259 United States, California University of Southern California Los Angeles, California, United States, 90033 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida Florida Cancer Specialists - South Fort Myers, Florida, United States, 33916 Florida Cancer Specialists - North Saint Petersburg, Florida, United States, 33705 United States, Illinois University of Chicago Cancer Center Chicago, Illinois, United States, 60637 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Cornell University New York, New York, United States, 10021 Columbia University Medical Center New York, New York, United States, 10032 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 United States, Pennsylvania Temple University Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT03257761 Extrahepatic Bile Duct Adenoca... More >>rcinoma, Biliary Type Gallbladder Adenocarcinoma, Biliary Type Metastatic Pancreatic Adenocarcinoma Recurrent Cholangiocarcinoma Recurrent Gallbladder Carcinoma Recurrent Hepatocellular Carcinoma Recurrent Intrahepatic Cholangiocarcinoma Recurrent Pancreatic Carcinoma Stage III Gallbladder Cancer AJCC V7 Stage III Hepatocellular Carcinoma AJCC v7 Stage III Intrahepatic Cholangiocarcinoma AJCC v7 Stage III Pancreatic Cancer AJCC v6 and v7 Stage IIIA Gallbladder Cancer AJCC v7 Stage IIIA Hepatocellular Carcinoma AJCC v7 Stage IIIB Gallbladder Cancer AJCC v7 Stage IIIB Hepatocellular Carcinoma AJCC v7 Stage IIIC Hepatocellular Carcinoma AJCC v7 Stage IV Gallbladder Cancer AJCC v7 Stage IV Hepatocellular Carcinoma AJCC v7 Stage IV Pancreatic Cancer AJCC v6 and v7 Stage IVA Gallbladder Cancer AJCC v7 Stage IVA Hepatocellular Carcinoma AJCC v7 Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7 Stage IVB Gallbladder Cancer AJCC v7 Stage IVB Hepatocellular Carcinoma AJCC v7 Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7 Unresectable Gallbladder Carcinoma Unresectable Pancreatic Carcinoma Less << Phase 1 Recruiting February 20, 2020 United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Marile Garcia, RN    323-865-0967    Marile.GarciaLeiva@med.usc.edu    Principal Investigator: Anthony El-Khoueiry          Hoag Memorial Hospital Presbyterian Recruiting Newport Beach, California, United States, 92663 Contact: Alicia Bogardus, MA       alicia.bogardus@hoag.org    Principal Investigator: Diana Hanna, MD          United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Candace Griffin    410-502-5568    cgriff22@jhmi.edu    Principal Investigator: Nilofer S. Azad, MD Less <<
NCT03220477 Lung Cancer Phase 1 Recruiting July 2020 United States, Maryland ... More >> John Hopkins Medical Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Jarushka Naidoo, M.B.B.Ch.    410-955-8866    Jhcccro@jhmi.edu    Principal Investigator: Jarushka Naidoo, M.B.B.Ch.          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Matthew Hellmann, MD    646-888-4863       Contact: Charles Rudin, MD, PhD    646-888-4527       Principal Investigator: Matthew Hellmann, MD          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Contact: Hossein Borghaei, MS, DO    888-369-2427 Less <<
NCT02608437 Metastatic Melanoma Phase 1 Unknown October 2018 Italy ... More >> Medical Oncology and Immunotherapy Unit, University Hospital of Siena Recruiting Siena, Italy, 53100 Contact: Anna Maria Di Giacomo, PhD, MD    +390577586305    a.m.digiacomo@ao-siena.toscana.it    Contact: Giovanni Amato, PhD    +390577586326    dataman.immonco@ao-siena.toscana.it Less <<
NCT02131597 High Risk Myelodysplastic Synd... More >>rome Less << Phase 2 Recruiting November 1, 2019 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Guillermo Garcia-Manero    713-745-3428    ggarciam@mdanderson.org    Principal Investigator: Guillermo Garcia-Manero Less <<
NCT03454984 Myelodysplastic Syndromes ... More >> Acute Myeloid Leukemia Less << Phase 2 Not yet recruiting March 2022 France ... More >> CHU d'Angers Not yet recruiting Angers, France, 49933 Contact: Sylvain THEPOT, md    33241354466    sylvain.thepot@chu-angers.fr    Principal Investigator: Sylvain THEPOT, md          CHU Estaing Not yet recruiting Clermont-Ferrand, France, 63000 Contact: Benoit DE RENZIS, MD    33473750065    bderenzis@chu-clermontferrand.fr    Principal Investigator: Benoit DE RENZIS, MD          Hôpital St Vincent de Paul Not yet recruiting Lille, France, 59020 Contact: Christian ROSE, prof    33320874532    Rose.Christian@ghicl.net    Principal Investigator: Christian ROSE, prof          CHU Nantes Not yet recruiting Nantes, France, 44093 Contact: Pierre PETERLIN, MD    33240083333    pierre.peterlin@chu-nantes.fr    Principal Investigator: Pierre PETERLIN, MD          Hôpital Archet 1 Not yet recruiting Nice, France, 06200 Contact: Thomas CLUZEAU, Prof    33492035844    cluzeau.t@chu-nice.fr    Hôpital St Louis Not yet recruiting Paris, France, 75010 Contact: Marie Robin, MD    33142499660    marie.robin@aphp.fr    Principal Investigator: Marie Robin, MD          Hôpital Pitié-Salpêtrière Paris, France, 75013 Hôpital Necker Not yet recruiting Paris, France, 75743 Contact: Felipe SUAREZ, MD    33144495368    felipe.suarez@aphp.fr    Principal Investigator: Felipe SUAREZ, MD          CHU de Haut-Lévèque Not yet recruiting Pessac, France, 33604 Contact: Sophie DIMICOLI-SALAZAR, md    33557656511    sophie.dimicoli-salazar@chu-bordeaux.fr    Principal Investigator: Sophie DIMICOLI-SALAZAR, MD          Centre Hospitalier Lyon-Sud Not yet recruiting Pierre-Bénite, France, 69495 Contact: Eric WATTEL, Prof    33478862205    eric.wattel@chu-lyon.fr    Principal Investigator: Eric WATTEL, Prof          CHU Toulouse - IUCT Oncopole Not yet recruiting Toulouse, France, 31059 Contact: Odile BEYNE-RAUZY, Prof    33531156248    beynerauzy.odile@iuct-oncopole.fr    Principal Investigator: Odile BEYNE-RAUZY, Prof          CHU Brabois Not yet recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Agnes GUERCI-BRESLER, md    33383153281    a.guerci@chru-nancy.fr    Principal Investigator: Agnes GUERCI-BRESLER, md Less <<
NCT02935361 Chronic Myelomonocytic Leukemi... More >>a Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes Less << Phase 1 Phase 2 Recruiting November 2, 2021 United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Casey L. O'Connell    323-865-3950    coconnel@usc.edu    Principal Investigator: Casey L. O'Connell          United States, Maryland University of Maryland Medical Center Not yet recruiting Baltimore, Maryland, United States, 21201 Contact: Maria R. Baer       MBaer@umm.edu    Principal Investigator: Maria R. Baer          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Patricia L. Kropf, MD    215-214-3119    Patricia.Kropf@tuhs.temple.edu    Contact: Lilanee Chanyothi, RN    215-214-3035    Lilanee.Chanyothi@tuhs.temple.edu    Principal Investigator: Patricia L. Kropf, MD          Temple University Hospital Not yet recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Patricia L. Kropf       Patricia.Kropf@tuhs.temple.edu    Principal Investigator: Patricia L. Kropf Less <<
NCT01696032 Ovarian Cancer Phase 2 Completed - -
NCT03308396 Advanced Kidney Cancer ... More >> Kidney Cancer Clear Cell Renal Cell Carcinoma Less << Phase 1 Phase 2 Recruiting December 1, 2020 United States, Illinois ... More >> Univerisity of Illinois Cancer Center Recruiting Chicago, Illinois, United States, 60612 Contact: Erin Vidra    312-996-7902    evidra@uic.edu    Principal Investigator: David Peace, MD          United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Ajjai Alva, M.D.    734-936-0091    ajjai@umich.edu    Contact: Carolina Fernandez-Castillo    734-763-8373    cefernan@med.umich.edu    United States, New Jersey Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Daniel Bell    732-235-9850    dwb90@cinj.rutgers.edu    Principal Investigator: Eric Singer, MD Less <<
NCT02901899 Recurrent Fallopian Tube Carci... More >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 2 Recruiting March 2020 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Daniela E. Matei    312-472-4684    daniela.matei@northwestern.edu    Principal Investigator: Daniela E. Matei, MD          Sub-Investigator: Emma Barber, MD          Sub-Investigator: Shohreh Shahabi, MD          Sub-Investigator: Wilberto Nieves-Neira, MD          Sub-Investigator: John Lurian, MD          The University of Chicago Medicine Recruiting Chicago, Illinois, United States, 60637 Contact: Gini Fleming, MD    773-702-6712       Principal Investigator: Gini Fleming, MD          Northwestern Lake Forest Hospital Recruiting Lake Forest, Illinois, United States, 60045 Contact: Valerine Nelson, MD    312-695-6180       Contact: Alok Pant, MD    (847)582-2134       Sub-Investigator: Valerine Nelson, MD          Sub-Investigator: Alok Pant, MD Less <<
NCT02429466 Germ Cell Tumor ... More >> Testis Cancer Testicular Cancer Less << Phase 1 Suspended December 31, 2019 United States, Indiana ... More >> Indiana University Hospital Indianapolis, Indiana, United States, 46202 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT03576963 Colorectal Adenocarcinoma ... More >> CpG Island Methylator Phenotype Metastatic Microsatellite Stable Colorectal Carcinoma Refractory Colorectal Carcinoma Stage IV Colorectal Cancer AJCC v8 Stage IVA Colorectal Cancer AJCC v8 Stage IVB Colorectal Cancer AJCC v8 Stage IVC Colorectal Cancer AJCC v8 Less << Phase 1 Phase 2 Not yet recruiting February 25, 2022 United States, California ... More >> USC / Norris Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90033 Contact: Dana Agafitei    323-865-0467    Raluca.Agafitei@med.usc.edu    Principal Investigator: Heinz-Josef Lenz, MD          Hoag Memorial Hospital Presbyterian Not yet recruiting Newport Beach, California, United States, 92658 Contact: Alicia Bogardus, MA    949-764-6755    Alicia.bogardus@hoag.org    Principal Investigator: Diana Hanna, MD Less <<
NCT02907359 Myelodysplastic Syndromes ... More >> Leukemia, Myelomonocytic, Chronic Less << Phase 3 Recruiting December 2019 -
NCT03603964 Acute Myeloid Leukemia ... More >> Myeloid Dysplastic Syndrome Less << Phase 2 Not yet recruiting July 1, 2020 United States, New York ... More >> Roswell Park Enrolling by invitation Buffalo, New York, United States, 14263 United States, North Carolina Duke Cancer Center Enrolling by invitation Durham, North Carolina, United States, 27705 United States, Ohio Ohio State University Enrolling by invitation Columbus, Ohio, United States, 43210 United States, Pennsylvania Temple University Enrolling by invitation Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Center for Blood Cancers Enrolling by invitation Nashville, Tennessee, United States, 37203 Austria Medizinische Universität Graz Enrolling by invitation Graz, Styria, Austria Canada, Ontario The Ottawa Hospital - General Enrolling by invitation Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Cancer Center Enrolling by invitation Toronto, Ontario, Canada, M5G 2M9 Denmark Rigshospitalet-Copenhagen University Hospital Enrolling by invitation Copenhagen, Denmark Italy Azienda Ospedaliera SS. Antonio E. Biagio E. Cesare Arrigo di Alessandria Enrolling by invitation Alessandria, Italy Azienda Ospedaliera Universitaria San Martino Enrolling by invitation Genova, Italy Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Enrolling by invitation Milano, Italy Azienda Ospedaliero Universitaria S. Maria della Misericordia di Udine Enrolling by invitation Udine, Italy Japan Tokai University Hospital Enrolling by invitation Isehara-shi, Japan, 259-1193 Japanese Red Cross Kyoto Daini Hospital Enrolling by invitation Kyoto-shi, Japan, 602-8026 Saga University Hospital Enrolling by invitation Saga-shi, Japan, 849-8501 Korea, Republic of Severance Hospital, Yonsei University Health System Enrolling by invitation Seoul, Korea, Republic of, 03722 Ulsan University Hospital Enrolling by invitation Ulsan, Korea, Republic of, 44033 Spain Hospital Universitario 12 de Octubre Enrolling by invitation Madrid, Spain Taiwan Mackay Memorial Hospital Enrolling by invitation Taipei, Taiwan National Taiwan University Hospital Enrolling by invitation Taipei, Taiwan Less <<
NCT02920008 Acute Myeloid Leukemia Phase 3 Active, not recruiting December 2019 -
NCT01896856 Previously Treated Metastatic ... More >>Colorectal Cancer Less << Phase 2 Recruiting September 2019 United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Anthony El-Khoueiry, MD    323-865-3967    elkhouei@med.usc.edu    United States, Maryland Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Ellen Lilly-Foreman, RN    443-287-4961    lillyel@jhmi.edu    Contact: Tearra Miles       tlawre18@jhmi.edu    Principal Investigator: Nilo Azad, MD          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Derek Alexander    646-888-1381    alexandd@mskcc.org    Principal Investigator: Andrea Cercek, MD          Netherlands VU Medisch Centrum Recruiting Amsterdam, Netherlands, 1081 HV Contact: Henk Verheul, MD       h.verheul@vumc.nl    Contact: Elske Gootjes, MD       e.gootjes@vumc.nl Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.79mL

0.36mL

0.18mL

8.97mL

1.79mL

0.90mL

17.94mL

3.59mL

1.79mL

References

 

Historical Records

Categories